Abstract:HBV capsid assembly has been viewed as an attractive target for new antiviral therapies against HBV. On the basis of a lead compound 4r, we further investigated this target to identify novel active compounds with appropriate anti-HBV potencies and improved pharmacokinetic (PK) properties. Structure–activity relationship studies based on metabolic pathways of 4r led to the identification of a phthalazinone derivative 19f with appropriate anti-HBV potencies (IC50 = 0.014 ± 0.004 μM in vitro), which demonstrated high oral bioavailability and liver exposure. In the AAV-HBV/mouse model, administration of 19f resulted in a 2.67 log reduction of the HBV DNA viral load during a 4-week treatment with 150 mg/kg dosing twice daily.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00346?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00346</a>.Tissue distributions profiles and plasma concentration–time curves in mice of 4r, 10m, and 19f; detailed experimental procedures for the synthesis of analogues 10a, 10b, 10i, 10j, 10k and intermediates 18h–18n; characterization (1H NMR spectra and 13C NMR spectra are attached) and HPLC purity control of the selected final compounds 10l, 10m, 18a, 18b, 18d, 18e, 18g, 19a–19h (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00346/suppl_file/jm0c00346_si_001.pdf">PDF</a>)Molecular-formula strings of the reported compounds and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00346/suppl_file/jm0c00346_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

The molecular simulation study for hepatitis B virus core protein and the nuclear protein allosteric modulators of phthalazinone derivatives.

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

A Molecular Simulation Study of Sulfonamide HBV Core Protein Allosteric Modulators

The SAR-based Development of Small Molecular HBV Capsid Assembly Modulators

A novel phthalazinone derivative as a capsid assembly modulator inhibits hepatitis B virus expression

Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors

Mechanism of Action, Clinical Research and Development, and Application Prospect of Hepatitis B Virus Core Protein Allosteric Modulators

Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics

Studies of Benzothiadiazine Derivatives As Hepatitis C Virus NS5B Polymerase Inhibitors Using 3D-QSAR, Molecular Docking and Molecular Dynamics.

Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators

In Silico Molecular Docking and Simulation Studies of Protein HBx Involved in the Pathogenesis of Hepatitis B Virus-HBV

HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways

Discovery of novel small molecules targeting hepatitis B virus core protein from marine natural products with HiBiT-based high-throughput screening

Allosteric conformational changes of human HBV core protein transform its assembly

A Novel Hepatitis B Virus Capsid Assembly Modulator QL-007 Inhibits HBV Replication and Infection Through Altering Capsid Assembly.

Preclinical Characterization of a Novel Potent Core Protein Assembly Modulator for the Treatment of Chronic Hepatitis B Viral Infection

Molecular Docking and Dynamic Simulation Studies of Benzoylated Emodin into HBV Core Protein

3D-QSAR, molecular docking and molecular dynamics simulations analyses of a series of heteroaryldihydropyrimidine derivatives as hepatitis B virus capsid assembly inhibitors

Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors

Pharmacophore-Based Virtual Screening and Structural Modification of Novel Benzamide Derivatives as HBV Capsid Assembly Modulators

Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations